Myriad Genetics, Inc. - stock earnings
MYGN Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| Aug. 1, 2024 BeforeMarket | - / - | 201.5 million | - / 204.9 million | 207.4 million |
MYGN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -31.2 million USD | 196.6 million USD |
| 2023Q3 | -61.3 million USD | 191.9 million USD |
| 2023Q2 | -116.1 million USD | 183.5 million USD |
| 2023Q1 | -54.7 million USD | 181.2 million USD |
| 2022Q4 | -42.3 million USD | 177.8 million USD |
| 2022Q3 | -35.1 million USD | 156.4 million USD |
| 2022Q2 | -14.1 million USD | 179.3 million USD |
| 2022Q1 | -20.5 million USD | 164.9 million USD |
| 2021Q4 | -7.6 million USD | 160.8 million USD |
| 2021Q3 | 24.6 million USD | 167.3 million USD |
| 2021Q2 | -4.7 million USD | 189.4 million USD |
| 2021Q1 | -39.5 million USD | 173.1 million USD |
| 2020Q4 | -44.2 million USD | 154.6 million USD |
| 2020Q3 | -15.2 million USD | 145.2 million USD |
| 2020Q2 | -55.4 million USD | 93.2 million USD |
| 2020Q1 | -115.2 million USD | 164.0 million USD |
| 2019Q4 | -8.3 million USD | 195.1 million USD |
| 2019Q3 | -20.6 million USD | 186.3 million USD |
| 2019Q2 | -4.2 million USD | 215.4 million USD |
| 2019Q1 | 6.9 million USD | 216.6 million USD |
| 2018Q4 | 2.6 million USD | 216.8 million USD |
| 2018Q3 | -700000 USD | 202.3 million USD |
| 2018Q2 | 13.1 million USD | 200.9 million USD |
| 2018Q1 | 11.4 million USD | 193.5 million USD |
| 2017Q4 | 32.1 million USD | 194.0 million USD |
| 2017Q3 | 81.1 million USD | 190.2 million USD |
| 2017Q2 | 12.9 million USD | 200.5 million USD |
| 2017Q1 | 4.2 million USD | 196.9 million USD |
| 2016Q4 | 5.9 million USD | 196.5 million USD |
| 2016Q3 | -1.2 million USD | 177.5 million USD |
| 2016Q2 | 23.4 million USD | 186.5 million USD |
| 2016Q1 | 32.6 million USD | 190.5 million USD |
| 2015Q4 | 30.3 million USD | 193.3 million USD |
| 2015Q3 | 26.6 million USD | 183.5 million USD |
| 2015Q2 | 18.7 million USD | 189.9 million USD |
| 2015Q1 | 21.5 million USD | 180.0 million USD |
| 2014Q4 | 24.0 million USD | 184.4 million USD |
| 2014Q3 | 16.0 million USD | 168.8 million USD |
| 2014Q2 | 33.6 million USD | 188.8 million USD |
| 2014Q1 | 36.8 million USD | 182.9 million USD |
| 2013Q4 | 50.4 million USD | 204.1 million USD |
| 2013Q3 | 55.5 million USD | 202.5 million USD |
| 2013Q2 | 44.1 million USD | 174.1 million USD |
| 2013Q1 | 37.9 million USD | 156.5 million USD |
| 2012Q4 | 35.0 million USD | 149.1 million USD |
| 2012Q3 | 30.1 million USD | 133.4 million USD |
| 2012Q2 | 29.1 million USD | 133.0 million USD |
| 2012Q1 | 29.6 million USD | 129.8 million USD |
| 2011Q4 | 28.3 million USD | 122.8 million USD |
| 2011Q3 | 25.1 million USD | 110.5 million USD |
| 2011Q2 | 26.0 million USD | 107.4 million USD |
| 2011Q1 | 27.9 million USD | 102.4 million USD |
| 2010Q4 | 24.2 million USD | 100.4 million USD |
| 2010Q3 | 22.5 million USD | 91.9 million USD |
| 2010Q2 | 53.3 million USD | 93.9 million USD |
| 2010Q1 | 33.3 million USD | 90.8 million USD |
| 2009Q4 | 35.4 million USD | 92.8 million USD |
| 2009Q3 | 30.4 million USD | 85.1 million USD |
| 2009Q2 | 23.6 million USD | 81.0 million USD |
| 2009Q1 | 25.3 million USD | 87.5 million USD |
| 2008Q4 | 21.2 million USD | 84.4 million USD |
| 2008Q3 | 14.5 million USD | 73.7 million USD |
| 2008Q2 | 65.5 million USD | 166.9 million USD |
| 2008Q1 | -4.6 million USD | 61.8 million USD |
| 2007Q4 | -5.1 million USD | 56.7 million USD |
| 2007Q3 | -8.0 million USD | 48.3 million USD |
| 2007Q2 | -7.8 million USD | 45.5 million USD |
| 2007Q1 | -5.9 million USD | 41.0 million USD |
| 2006Q4 | -8.8 million USD | 37.1 million USD |
| 2006Q3 | -12.4 million USD | 33.5 million USD |
| 2006Q2 | -11.4 million USD | 32.0 million USD |
| 2006Q1 | -9.6 million USD | 29.8 million USD |
| 2005Q4 | -8.0 million USD | 27.3 million USD |
| 2005Q3 | -9.2 million USD | 25.1 million USD |
| 2005Q2 | -10.0 million USD | 26.1 million USD |
| 2005Q1 | -10.0 million USD | 20.0 million USD |
| 2004Q4 | -10.0 million USD | 19.6 million USD |
| 2004Q3 | -10.0 million USD | 16.7 million USD |
| 2004Q2 | -10.5 million USD | 15.1 million USD |
| 2004Q1 | -10.7 million USD | 13.8 million USD |
| 2003Q4 | -9.9 million USD | 14.1 million USD |
| 2003Q3 | -9.6 million USD | 13.7 million USD |
| 2003Q2 | -7.1 million USD | 15.7 million USD |
| 2003Q1 | -5.5 million USD | 16.1 million USD |
| 2002Q4 | -6.9 million USD | 17.0 million USD |
| 2002Q3 | -5.3 million USD | 15.5 million USD |
| 2002Q2 | -6.8 million USD | 14.1 million USD |
| 2002Q1 | -3.5 million USD | 13.1 million USD |
| 2001Q4 | -2.5 million USD | 13.5 million USD |
| 2001Q3 | -1.2 million USD | 13.2 million USD |
| 2001Q2 | -2.2 million USD | 10.8 million USD |
| 2001Q1 | -1.7 million USD | 11.6 million USD |
| 2000Q4 | -1.2 million USD | 12.0 million USD |
| 2000Q3 | -2.1 million USD | 10.8 million USD |
| 2000Q2 | -2.6 million USD | 9.2 million USD |
| 2000Q1 | -2.1 million USD | 9.7 million USD |
| 1999Q4 | -1.9 million USD | 8.3 million USD |
| 1999Q3 | -2.2 million USD | 6.9 million USD |
| 1999Q2 | -2.3 million USD | 6.9 million USD |
| 1999Q1 | -2.2 million USD | 7.1 million USD |
| 1998Q4 | -2.9 million USD | 5.7 million USD |
| 1998Q3 | -2.7 million USD | 5.6 million USD |
| 1998Q2 | -3.1 million USD | 6.5 million USD |
| 1998Q1 | -2.6 million USD | 5.7 million USD |
| 1997Q4 | -2.3 million USD | 5.1 million USD |
| 1997Q3 | -1.8 million USD | 5.9 million USD |
| 1997Q2 | 300000 USD | 7.5 million USD |
| 1997Q1 | -3.2 million USD | 2.7 million USD |
| 1996Q4 | -3.5 million USD | 2.8 million USD |
| 1996Q3 | -2.8 million USD | 2.2 million USD |
| 1996Q2 | -1.9 million USD | 2.0 million USD |
| 1996Q1 | -1.8 million USD | 1.9 million USD |
| 1995Q4 | -700000 USD | 1.7 million USD |
| 1995Q3 | -1.6 million USD | 1.0 million USD |
MYGN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -112.0 million USD | 678.4 million USD |
| 2022 | -27.2 million USD | 690.6 million USD |
| 2021 | -223.7 million USD | 557.0 million USD |
| 2020 | 4.6 million USD | 851.1 million USD |
| 2019 | 4.6 million USD | 851.1 million USD |
| 2018 | 131.0 million USD | 772.6 million USD |
| 2017 | 21.8 million USD | 771.4 million USD |
| 2016 | 125.3 million USD | 753.8 million USD |
| 2015 | 80.2 million USD | 723.1 million USD |
| 2014 | 176.2 million USD | 778.2 million USD |
| 2013 | 147.1 million USD | 613.2 million USD |
| 2012 | 112.2 million USD | 496.0 million USD |
| 2011 | 100.7 million USD | 402.1 million USD |
| 2010 | 152.3 million USD | 362.6 million USD |
| 2009 | 84.6 million USD | 326.5 million USD |
| 2008 | 47.8 million USD | 333.6 million USD |
| 2007 | -35.0 million USD | 157.1 million USD |
| 2006 | -38.2 million USD | 114.3 million USD |
| 2005 | -40.0 million USD | 82.4 million USD |
| 2004 | -40.6 million USD | 56.6 million USD |
| 2003 | -24.8 million USD | 64.3 million USD |
| 2002 | -14.0 million USD | 53.8 million USD |
| 2001 | -7.2 million USD | 45.2 million USD |
| 2000 | -8.7 million USD | 34.0 million USD |
| 1999 | -10.0 million USD | 25.3 million USD |
| 1998 | -9.8 million USD | 23.2 million USD |
| 1997 | -9.2 million USD | 15.2 million USD |
| 1996 | -5.9 million USD | 6.6 million USD |
MYGN
Price: $25.29
52 week price:
Earnings Per Share: -3.18 USD
P/E Ratio: -6.54
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 315100
Ebitda: 17.5 millionMarket Capitalization: 2.3 billion